Provera
NDC Package 54868-1010-4

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Provera is medroxyprogesterone is a type of female hormone (progestin). Marketed by Physicians Total Care, Inc., this product is identified by NDC 54868-1010 and is authorized under FDA application NDA011839.

Identification & Billing

NDC Package Code
54868-1010-4
Package Description
30 TABLET in 1 BLISTER PACK
Product Code
54868-1010
11-Digit Billing Format
54868101004

Clinical Specifications

Proprietary Name
Provera
Dosage Form
-
Usage Information
Medroxyprogesterone is a type of female hormone (progestin). This medication is similar to the progesterone that your body naturally makes and is given to replace the hormone when your body is not making enough of it. This medication has several uses. In women who are not pregnant and not going through menopause, this medication is used to treat abnormal bleeding from the uterus and to restore normal menstrual periods in women who have stopped having them for several months (amenorrhea). Medroxyprogesterone is also used as part of combination hormone replacement therapy with estrogens to reduce menopause symptoms (e.g., hot flashes). Medroxyprogesterone is added to estrogen replacement therapy to reduce the risk of cancer of the uterus. This medication must not be used to test for pregnancy.

Regulatory & Marketing

Labeler Name
Physicians Total Care, Inc.
FDA Application #
NDA011839
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-03-1959
End Marketing Date
06-30-2011
Listing Expiration
06-30-2011
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (54868-1010). Click a package code to view its specific billing and regulatory data.

54868-1010-1
30 TABLET in 1 BOTTLE
54868-1010-3
40 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 54868-1010-4 identifies a specific commercial package of 30 tablet in 1 blister pack of Provera, labeled by Physicians Total Care, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Physicians Total Care, Inc. on June 03, 1959. The current certification is valid through June 30, 2011.

What are the primary indications for this medication?

Medroxyprogesterone is a type of female hormone (progestin). This medication is similar to the progesterone that your body naturally makes and is given to replace the hormone when your body is not making enough of it. This medication has several uses. In women who are not pregnant and not going through menopause, this medication is used to treat abnormal bleeding from the uterus and to restore normal menstrual periods in women who have stopped having them for several months (amenorrhea). Medroxyprogesterone is also used as part of combination hormone replacement therapy with estrogens to reduce menopause symptoms (e.g., hot flashes). Medroxyprogesterone is added to estrogen replacement therapy to reduce the risk of cancer of the uterus. This medication must not be used to test for pregnancy.

How is this Physicians Total Care, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 54868101004. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
54868-1010-4
11-Digit CMS (5-4-2)
54868-1010-04

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.